SCHEMBL27760010

SCHEMBL27760010

NC(=O)N(c1ccc(Br)cc1F)c1cc(C(F)(F)F)ccc1F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.41
KIF11 P52732 1/20 0.34
PPARD Q03181 1/20 0.34
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
GAA P10253 1/20 0.33
MPO P05164 1/20 0.33
KDR P35968 1/20 0.33
TMPRSS4 Q9NRS4 2/20 0.33
MEN1 O00255 1/20 0.33
TSHR P16473 1/20 0.33
KMT2A Q03164 1/20 0.33
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA9 Q16790 1/20 0.32
IDO1 P14902 1/20 0.32
CES2 O00748 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27747320 0.82 MPO (0.39) DGAT1KIF11ALDH1A1GAAMPO
SCHEMBL27672611 0.76 MPL (0.33) KIF11KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4798418 0.75 GAA (0.36) KIF11KDM4EALDH1A1HPGDHSD17B10
SCHEMBL27760015 0.74 IDO1 (0.36) KIF11KDRKMT2AIDO1
SCHEMBL2010240 0.74 CYP2D6 (0.41) KIF11KDM4EALDH1A1HPGDHSD17B10
SCHEMBL5311347 0.74 KMT2A (0.35) KIF11KMT2ACA12CA1CA2
SCHEMBL6258541 0.73 SCN8A (0.40) KDM4E
SCHEMBL5247534 0.72 KMT2A (0.47) KIF11KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6249698 0.72 MAPT (0.43) KDM4EALDH1A1HPGDKMT2A
SCHEMBL27528049 0.71 SMN1; SMN2 (0.37) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105732634-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis 拜尔健康护理有限责任公司 2016-07-06 CN disclosed
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed
CN-101365454-A Substituted 4-amino-pyrrolotriazine derivatives for the treatment of hyperproliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-02-11 CN disclosed